A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
This study is to evaluate how safe and effective ritlecitinib is in participants with non-segmental vitiligo (NSV). Ritlecitinib is studied in patients with non-segmental vitiligo. Vitiligo is a chro...
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo....
Top Cities for Vitiligo Clinical Trials
Vitiligo clinical trials are recruiting across 19 cities. Here are the cities with the most active studies:
About Vitiligo
Vitiligo is a condition that causes loss of skin color in patches due to destruction of melanocytes. It affects about 1% of the global population. Treatment options include topical corticosteroids, phototherapy, JAK inhibitors, and skin grafting.
Clinical trials are advancing new treatments for vitiligo. Currently, 2 studies are recruiting a combined 580 participants across the United States. Research is being conducted by 2 organizations including Pfizer, Incyte Corporation.
2026 Vitiligo Research Landscape
As of March 2026, the vitiligo clinical trial landscape includes 2 actively recruiting studies across 19 cities in the United States. These studies are collectively seeking 580 participants, with an average enrollment target of 290 per study.
Research is being led by 2 different organizations, including Pfizer, Incyte Corporation.
Geographically, vitiligo trials are most concentrated in Phoenix, Arizona (2 trials); Encinitas, California (1 trial); Huntington Beach, California (1 trial); Los Angeles, California (1 trial); Boynton Beach, Florida (1 trial) and 7 other cities.
Featured Vitiligo Studies
Highlighted recruiting studies for vitiligo, selected by enrollment size and research scope.
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
This study is to evaluate how safe and effective ritlecitinib is in participants with non-segmental vitiligo (NSV). Ritlecitinib is studied in patients with non-segmental vitiligo. Vitiligo is a chronic acquired depigmentation disorder characterized by well-defined pale white patches of skin. Non-segmental vitiligo is an autoimmune disorder and is the focus of this study. The study will show: *...
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
The purpose of this study is to to evaluate the safety and efficacy of ruxolitinib cream in pediatric participants with nonsegmental vitiligo.
Frequently Asked Questions About Vitiligo Clinical Trials
Are there vitiligo clinical trials near me?
Yes, there are 2 vitiligo clinical trials currently recruiting across 19+ cities in the United States, including Phoenix, Arizona; Encinitas, California; Huntington Beach, California. Browse the studies above to find one at a location convenient for you.
How do I join a vitiligo clinical trial?
To join a vitiligo clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are vitiligo clinical trials free?
Yes, participation in vitiligo clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of vitiligo treatments are being studied?
Current vitiligo clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 2 research organizations.
Is it safe to participate in vitiligo clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov